MedPath

An observational study on the presence of inflammatory changes in the mucosa of the sigmoid colon in asymptomatic individuals with diverticular disease and the correlation with colon microbiology

Recruiting
Conditions
Diverticular disease
diverticulosis
10013535
Registration Number
NL-OMON36560
Lead Sponsor
Kennemer Gasthuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

• Eighteen years or older;
• Scheduled for colonoscopy for:
1. Hematochezia;
2. gastrointestinal hemorrhage;
3. unexplained changes in bowel habit;
4. weight loss;
5. iron-deficiency anemia;
6. chronic obstipation without positive reaction on the treatment;
7. screening for and follow-up of colorectal cancer;

Exclusion Criteria

• Suspicion of diverticular related complaints;
• Proven history of symptomatic diverticular disease;
• Use of coumarin derivates, unless stopped one week before colonoscopy;
• Use of NSAID*s unless stopped one week before colonoscopy;
• Use of platelet aggregate inhibitors, including aspirin, unless stopped one week before colonoscopy;
• Sedation before informed consent;
• History of inflammatory bowel disease;
• Endoscopic signs of inflammation.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Inflammation, defined as mean T lymphocyte count and neutrophil count in the<br /><br>mucosa of the colon. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Colonic flora, expressed as anaerobic/ aerobic ratio and presence or absence of<br /><br>certain strains of bacteria by means of micro-array.</p><br>
© Copyright 2025. All Rights Reserved by MedPath